Mazdutide

DB19099InvestigationalProtein Based Therapies

Mazdutide is under investigation in clinical trial NCT06143956 (A Chronic Weight Management Master Protocol Study (LY900038) of Multiple Intervention-specific-appendices (Isas) in Adult Participants With Obesity or Overweight).

Mechanism: Pharmacologically active on Glucagon receptor and Glucagon-like peptide 1 receptor
Curator reviewed
Code names: IBI-362 · LY-3305677

Resolves to

Compound

UNIIMB76Z4IBZ5CAS2259884-03-0

Targets

P47871GCGRP43220GLP1R

What you can answer from here — as of July 09, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

40Clinical trialsPhase, status and sponsor resolved per trial

12+ReferencesStructured and connected to the statements they support

Which drugs share a target with Mazdutide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account